Please login to the form below

Not currently logged in
Email:
Password:

EngMab

This page shows the latest EngMab news and features for those working in and with pharma, biotech and healthcare.

Celgene steps back from $1bn Sutro acquisition

Celgene steps back from $1bn Sutro acquisition

It already has a BCMA candidate in-house after buying EngMab for $625m last year, for example.

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    Another company rarely away from the deal headlines is Celgene. This month Celgene acquired the company EngMab paying $600m for the privilege. ... 624. EngMab / Celgene. Acquisition corporate. T cell bispecific antibodies that bind simultaneously to a

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...